GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (TSE:4523) » Definitions » Total Equity

Eisai Co (TSE:4523) Total Equity : 円842,715 Mil (As of Dec. 2023)


View and export this data going back to 1961. Start your Free Trial

What is Eisai Co Total Equity?

Eisai Co's total equity for the quarter that ended in Dec. 2023 was 円842,715 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Eisai Co Total Equity Historical Data

The historical data trend for Eisai Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Total Equity Chart

Eisai Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 651,982.00 702,630.00 726,360.00 771,533.00 822,571.00

Eisai Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 797,072.00 822,571.00 867,662.00 884,845.00 842,715.00

Eisai Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Eisai Co's Total Equity for the fiscal year that ended in Mar. 2023 is calculated as

Total Equity=Total Assets(Q: Mar. 2023 )-Total Liabilities(Q: Mar. 2023 )
=1263350-440779
=822,571

Eisai Co's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=1311234-468519
=842,715

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eisai Co Total Equity Related Terms

Thank you for viewing the detailed overview of Eisai Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Eisai Co (TSE:4523) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (TSE:4523) » Definitions » Total Equity
Comparable Companies
TSE:4507 TSE:4581 TSE:4516 TSE:4530 TSE:4540 TSE:4887 TSE:4506 TSE:4547 TSE:4553 TSE:4521 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA VTRS NBIX XSWX:SDZ SZSE:000538
Traded in Other Exchanges
ESAIY:USA ESALF:USA EII:Germany
Address
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Website
http://www.eisai.co.jp
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Eisai Co (TSE:4523) Headlines

No Headlines